FindTrial
Sign In

Study to assess fever and low cell count after chemotherapy

Demographic Profile of Chemotherapy induced Febrile Neutropenia at a tertiary care hospital in Coastal Karnataka - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063240
Enrollment
150
Registered
2024-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D701- Agranulocytosis secondary to cancer chemotherapy

Interventions

Control Intervention1: NIL: NIL

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult Male and Female Cancer patients who develop Febrile Neutropenia following chemotherapy at our hospital Febrile Neutropenia is defined as an oral body temperature of more than 38.3 Celsius or two consecutive readings of more than 38.0 Celsius after two hours with an absolute neutrophil count below or expected to fall below 500 per uL of blood

Exclusion criteria

Exclusion criteria: Patients who come to our hospital only for an opinion and take treatment elsewhere Patients whose disease or treatment details are not available

Design outcomes

Primary

MeasureTime frame
patient status: dead or aliveTimepoint: till the end of febrile neutropenia episode—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Sharada M

Kasturba Medical College Manipal

sharada.m@manipal.edu9787689031

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026